These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8555595)

  • 21. [Treatment of sepsis by extracorporeal elimination of endotoxin using fiber-immobilized polymyxin B].
    Aoki H; Tani T; Hanasawa K; Shoji H; Kodama M
    Nihon Geka Gakkai Zasshi; 1993 Aug; 94(8):775-80. PubMed ID: 8377751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
    Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S
    Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endotoxin removal: how far from the evidence? From EUPHAS to EUPHRATES.
    Rachoin JS; Foster D; Dellinger RP
    Contrib Nephrol; 2010; 167():111-118. PubMed ID: 20519905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymyxin B for endotoxin removal in sepsis.
    Cavaillon JM
    Lancet Infect Dis; 2011 Jun; 11(6):426-7. PubMed ID: 21616454
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical effects of polymyxin B-immobilized fiber column in septic patients.
    Cruz DN; Bellomo R; Ronco C
    Contrib Nephrol; 2007; 156():444-51. PubMed ID: 17464156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PMX endotoxin removal in the clinical practice: results from the EUPHAS trial.
    Antonelli M; Fumagalli R; Cruz DN; Brienza N; Giunta F
    Contrib Nephrol; 2010; 167():83-90. PubMed ID: 20519902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
    Nakamura T; Suzuki T; Kawagoe Y; Koide H
    ASAIO J; 2008; 54(2):210-3. PubMed ID: 18356658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected gram-negative sepsis.
    Balogun RA
    Crit Care Med; 2005 Feb; 33(2):461-2. PubMed ID: 15699862
    [No Abstract]   [Full Text] [Related]  

  • 30. Mortality Effects of Prolonged Hemoperfusion Therapy Using a Polymyxin B-Immobilized Fiber Column for Patients with Septic Shock: A Sub-Analysis of the DESIRE Trial.
    Kawazoe Y; Sato T; Miyagawa N; Yokokawa Y; Kushimoto S; Miyamoto K; Ohta Y; Morimoto T; Yamamura H
    Blood Purif; 2018; 46(4):309-314. PubMed ID: 30099437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The removal of 14C labeled endotoxin by activated charcoal.
    Pegues AS; Sofer SS; McCallum RE; Hinshaw LB
    Int J Artif Organs; 1979 May; 2(3):153-8. PubMed ID: 381215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of polymyxin B convalently immobilized fiber in patients with septic shock.
    Suzuki H; Shoji H
    Contrib Nephrol; 2010; 166():150-157. PubMed ID: 20473003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: report of a case.
    Sakamoto Y; Mashiko K; Matsumoto H; Hara Y; Kutsukata N; Takei K; Ueno Y; Tomita Y; Yamamoto Y
    ASAIO J; 2006; 52(6):e37-9. PubMed ID: 17117045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of cationically modified cellulose adsorbents for the removal of endotoxins.
    Weber C; Henne B; Loth F; Schoenhofen M; Falkenhagen D
    ASAIO J; 1995; 41(3):M430-4. PubMed ID: 8573840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
    Kodama M; Tani T; Maekawa K; Hirasawa H; Otsuka T; Takahashi Y; Kaneko M
    Nihon Geka Gakkai Zasshi; 1995 May; 96(5):277-85. PubMed ID: 7596338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M; Sato N; Yaegashi Y; Suzuki Y; Suzuki K; Nakae H; Endo S
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical experiences of endotoxin removal in urinary obstruction: report of two cases].
    Sugi M
    Hinyokika Kiyo; 2004 Oct; 50(10):685-9. PubMed ID: 15575218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotoxin removal: how far from the evidence? The EUPHAS 2 Project.
    Martin EL; Cruz DN; Monti G; Casella G; Vesconi S; Ranieri VM; Ronco C; Antonelli M
    Contrib Nephrol; 2010; 167():119-125. PubMed ID: 20519906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical experiences of endotoxin removal columns in septic shock due to urosepsis: report of three cases].
    Yuasa J; Naya Y; Tanaka M; Amakasu M; Yamaguchi K
    Hinyokika Kiyo; 2000 Nov; 46(11):819-22. PubMed ID: 11193305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of a novel endotoxin adsorber polyvinylidene fluoride fiber immobilized with (L)-serine ligand on septic pigs.
    Gao JP; Huang M; Li N; Wang PF; Chen HL; Xu QP
    J Zhejiang Univ Sci B; 2011 Apr; 12(4):264-72. PubMed ID: 21462381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.